Find clinical trials for Multiple Myeloma in Boston, MA

This research is being done to determine if the combination of the Dendritic Cell (DC)/ Multiple Myeloma (MM) fusion vaccine with e ...

if the study drug, elranatamab, reduces the risk of disease progression (worsening disease) after idecabtagene vicleucel in relapsed refractory multiple...

This research study is studying a combination of study drugs as a possible treatment for relapsed and refractory Multiple Myeloma. ...

This research study is studying a targeted therapy as a possible treatment for multiple myeloma.The names of the study drugs involv...

pomalidomide, and dexamethasone in relapsed and refractory multiple myeloma. The study drugs provided for research purposes are isa...

This research study is studying a drug as a possible treatment for Monoclonal Gammopathy of Unknown Significance (MGUS) or Smoldering Multiple...

The purpose of this study is to evaluate the safety and preliminary efficacy of CC-92480 in combination with standard treatments.

the combination of daratumumab, lenalidomide, bortezomib, dexamethasone for patients with newly diagnosed, transplant ineligible/deferred multiple...

The purpose of this study is to evaluate the safety and tolerability of mRNA-2808 in participants with relapsed or refractory multiple myeloma...

and dexamethasone combination in patients with newly diagnosed multiple myeloma. We are looking for the highest dose of the combina...